日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial

Naxitamab联合递增剂量粒细胞-巨噬细胞集落刺激因子治疗原发性难治性高危神经母细胞瘤:一项I/II期试验的结果

Kushner, Brian H; Modak, Shakeel; Mauguen, Audrey; Basu, Ellen M; Roberts, Stephen S; Cheung, Nai-Kong V

Clonal evolution during metastatic spread in high-risk neuroblastoma

高危神经母细胞瘤转移扩散过程中的克隆演变

Gundem, Gunes; Levine, Max F; Roberts, Stephen S; Cheung, Irene Y; Medina-Martínez, Juan S; Feng, Yi; Arango-Ossa, Juan E; Chadoutaud, Loic; Rita, Mathieu; Asimomitis, Georgios; Zhou, Joe; You, Daoqi; Bouvier, Nancy; Spitzer, Barbara; Solit, David B; Dela Cruz, Filemon; LaQuaglia, Michael P; Kushner, Brian H; Modak, Shakeel; Shukla, Neerav; Iacobuzio-Donahue, Christine A; Kung, Andrew L; Cheung, Nai-Kong V; Papaemmanuil, Elli

Immunotherapy with anti-G(D2) monoclonal antibody in infants with high-risk neuroblastoma

对患有高危神经母细胞瘤的婴儿进行抗G(D2)单克隆抗体免疫治疗

Kushner, Brian H; Modak, Shakeel; Kramer, Kim; Basu, Ellen M; Iglesias-Cardenas, Fiorella; Roberts, Stephen S; Cheung, Nai-Kong V

High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women

高强度运动训练可改善绝经后女性基础血小板前列环素敏感性并增强对双重抗血小板治疗的反应

Kate A Wickham, Line B Nørregaard, Martina H Lundberg Slingsby, Stephen S Cheung, Ylva Hellsten

Short-Term Supplementation With Fermented Red Clover Extract Reduces Vascular Inflammation in Early Post-menopausal Women

短期补充发酵红三叶草提取物可减少绝经后早期女性的血管炎症

Kate A Wickham, Line B Nørregaard, Mikkel Oxfeldt, Stephen S Cheung, Lasse Gliemann, Mette Hansen, Ylva Hellsten

Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial

人源化3F8抗GD2单克隆抗体联合粒细胞-巨噬细胞集落刺激因子治疗耐药性神经母细胞瘤患者:一项I期临床试验

Kushner, Brian H; Cheung, Irene Y; Modak, Shakeel; Basu, Ellen M; Roberts, Stephen S; Cheung, Nai-Kong

Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

抗GD2单克隆抗体hu3F8联合GM-CSF的I期临床试验:体重、免疫原性和抗GD2反应对药代动力学和生存率的影响

Cheung, Irene Y; Kushner, Brian H; Modak, Shakeel; Basu, Ellen M; Roberts, Stephen S; Cheung, Nai-Kong V

Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study

贝伐珠单抗、伊立替康和替莫唑胺联合治疗难治性或复发性神经母细胞瘤:一项 II 期研究的结果

Modak, Shakeel; Kushner, Brian H; Basu, Ellen; Roberts, Stephen S; Cheung, Nai-Kong V

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era

当代MYCN扩增型神经母细胞瘤预后呈现显著的两极分化

Kushner, Brian H; Modak, Shakeel; Kramer, Kim; LaQuaglia, Michael P; Yataghene, Karima; Basu, Ellen M; Roberts, Stephen S; Cheung, Nai-Kong V